Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence: response to comments by Ezziddin et al.

被引:0
作者
Campana, Davide [1 ,4 ]
Delle Fave, Gianfranco [2 ]
Falconi, Massimo [3 ]
Tommassetti, Paola [1 ]
机构
[1] Univ Bologna, Dept Med & Surg Sci, Policlin S Orsola Malpighi, I-40138 Bologna, Italy
[2] Univ Roma La Sapienza, Digest & Liver Dis Unit, I-00185 Rome, Italy
[3] Univ Politecn Marche, Dept Surg, Ancona, Italy
[4] Univ Bologna, Dept Clin Med, Policlin S Orsola Malpighi, I-40138 Bologna, Italy
关键词
PANCREATIC ENDOCRINE TUMORS; DISEASE PROGRESSION; PROGNOSTIC-FACTORS; GRADING SYSTEM; SURVIVAL; TOXICITY;
D O I
10.1007/s00259-013-2603-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:176 / 177
页数:2
相关论文
共 2 条
  • [1] Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence
    Campana, Davide
    Capurso, Gabriele
    Partelli, Stefano
    Nori, Francesca
    Panzuto, Francesco
    Tamburrino, Domenico
    Cacciari, Giulia
    Delle Fave, Gianfranco
    Falconi, Massimo
    Tomassetti, Paola
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (08) : 1197 - 1205
  • [2] Response to comments on 'Malignant mesothelioma diagnosed at a younger age is associated with heavier asbestos exposure' by Farioli et al. and Oddone et al.
    Dragani, Tommaso A.
    Colombo, Francesca
    Pavlisko, Elizabeth N.
    Roggli, Victor L.
    CARCINOGENESIS, 2019, 40 (03) : 490 - 491